Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • License checker
  • Guides
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal

Federal regulations

Agency
  • SEC229
  • HHS221
  • DOC218
  • DOT
211
  • FDA194
  • DOE160
  • DHS154
  • FERC142
  • FAA111
  • EPA92
  • DOJ73
  • NOAA68
  • USDA65
  • Treasury64
  • NIH56
  • DOL47
  • FCC29
  • SBA29
  • HUD22
  • CMS18
  • IRS16
  • FTC4
  • Topic
    • Compliance2
    • Tax2
    • Finance1
    Recency
    • Last 30 days
    • Last 7 days
    FDARemove filter: FDAFTCRemove filter: FTCIRSRemove filter: IRSNIHRemove filter: NIHClear all
    • Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings
      July 6, 2026

      FDA submitted a proposed information collection to OMB for Paperwork Reduction Act review regarding formal hearing administrative procedures and practices.

    • Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
      July 6, 2026

      FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.

    • Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
      July 6, 2026

      FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.

    • Agency Information Collection Activities; Proposed Collection; Comment Request; Biologics License Applications, Procedures and Requirements
      July 6, 2026

      FDA seeks 60 days of public comment on information collection requirements for Biologics License Applications under the Paperwork Reduction Act; deadline for comments is 60 days from Federal Register publication.

    • Proposed Collection; 60-day Comment Request; Generic Clearance for NIH Citizen Science and Crowdsourcing Projects (Office of the Director)
      July 6, 2026

      NIH requests 60-day public comment on proposed data collection for citizen science and crowdsourcing projects under Paperwork Reduction Act review; deadline is 60 days from publication.

    • Center for Scientific Review; Notice of Closed Meetings
      July 6, 2026

      Center for Scientific Review holds closed peer-review meetings to evaluate competitive grant applications across federal research programs and funding agencies.

    • Expedited Investigational New Drug Pilot Program; Request for Information; Correction
      July 6, 2026

      FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.

    • Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Approval of Medical Devices
      July 6, 2026

      The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.

    • Voluntary Recall of Two Lots of PEDIGREE® Can High Protein Chopped Chicken & Duck Flavor Wet Dog Food Due to Potential Fraudulent Distribution of Product Which May Contain Foreign Material
      July 3, 2026

      Mars Petcare US voluntarily recalls two lots of PEDIGREE Can High Protein Chopped Chicken & Duck Flavor 13.2oz dog food due to potential fraudulent distribution and foreign material contamination.

    • Gellert Global Group Issues Allergy Alert on Undeclared Tuna (Fish) in Aldi Brand Fusia Asian Inspirations Kimchi and Tofu Kimbap
      July 2, 2026

      Gellert Global Group recalls 8.1 oz packages of Aldi Brand Fusia Asian Inspirations Kimchi & Tofu Kimbap due to undeclared tuna that poses serious allergic reaction risk to consumers with fish allergies.

    Page 1 of 27 (270 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois
    • Kentucky

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants